Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[Phase III study]

¹Dept. of Internal Medicine, National Kinki Central Hospital for Chest Disease, Sakai, Japan.

Gan to Kagaku Ryoho. Cancer & Chemotherapy

|April 1, 1995

Summary

This summary is machine-generated.

Phase III clinical studies rigorously assess new treatments against placebos or standard therapies to determine effectiveness and toxicity. This phase is crucial for confirming a drug's therapeutic value and safety profile before market approval.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Histological Examination of Bronchial Mucosa after Photodynamic Therapy Showing no Selectivity of Effect between Tumour and Normal Mucosa.

Lasers in medical science·2014

Same author

Chemotherapy-induced neutropenia as a prognostic factor in advanced non-small-cell lung cancer: results from Japan Multinational Trial Organization LC00-03.

British journal of cancer·2009

Same author

Photon emissions from rice cells elicited by N-acetylchitooligosaccharide are generated through phospholipid signaling in close association with the production of reactive oxygen species.

Plant physiology and biochemistry : PPB·2006

Same author

Critical factors for patient management.

Lung cancer (Amsterdam, Netherlands)·2004

Same author

Consensus: the follow-up of the treated patient.

Lung cancer (Amsterdam, Netherlands)·2004

Same author

[A resected case of malignant fibrous histiocytoma of the chest wall].

Kyobu geka. The Japanese journal of thoracic surgery·2003

Same journal

[A Case of Pulmonary Epithelioid Hemangioendothelioma Associated with Multiple Cancers].

Gan to kagaku ryoho. Cancer & chemotherapy·2026

Same journal

[Long-Term Survival in Three Cases with Pulmonary Metastases from Colorectal Cancer Given Low-Dose S-1 Under a Regimen Combining a Carbohydrate-Restricted Ketogenic Diet, Metformin, Vitamin D, Eicosapentaenoic Acid, and Other Complementary Therapies].

Gan to kagaku ryoho. Cancer & chemotherapy·2026

Same journal

[Preventive Effect of Saline Eye Wash for Eye Symptoms Due to High-Dose and Intermediate-Dose Cytarabine Therapy].

Gan to kagaku ryoho. Cancer & chemotherapy·2026

Same journal

[Examination of Factors Affecting the Efficacy of Naldemedine Tosilate Tablets for Opioid-Induced Constipation].

Gan to kagaku ryoho. Cancer & chemotherapy·2026

Same journal

[Recent Advances in the Treatment of HER2-Altered Solid Tumors].

Gan to kagaku ryoho. Cancer & chemotherapy·2026

Same journal

[BRAF-Mutant Solid Tumor].

Gan to kagaku ryoho. Cancer & chemotherapy·2026

See all related articles

Area of Science:

Clinical Pharmacology
Drug Development
Medical Research

Context:

Phase II studies identify minimal drug activity, necessitating further investigation.
Subsequent clinical trials compare new treatments against established benchmarks.

Purpose:

To evaluate the efficacy of novel therapeutic interventions.
To assess the safety and toxicity profiles of new drug candidates.
To establish the comparative effectiveness against placebo or standard care.

Summary:

Phase III studies represent the most extensive and rigorous stage of clinical investigation.
These trials are designed to confirm preliminary findings on drug activity and establish a clear benefit-risk assessment.
Key objectives include demonstrating superiority or non-inferiority to existing treatments and identifying adverse events.

Related Experiment Videos

Impact:

Informs regulatory decisions regarding drug approval and market access.
Provides critical data for healthcare providers to make informed treatment choices.
Contributes to the overall body of evidence guiding therapeutic strategies and patient outcomes.